| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |